BROADCASTS.com

*Disclaimer* Johns Hopkins has Regulatory Approval and is allowed to conduct these clinical setting experiences with the use of these compunds. Psychedelics still remain Schedule 1 Drugs in the United States, i.e., they are illegal. This podcast is not advocating for the use or distribution on these drugs, and this podcast is not advice for these compounds. Again, we are not telling you to use these psychedelic substances. This is merely a conversation.  In this episode, Dr. Sandeep Nayak joined me to discuss the possible benefits of the use of psychedelics in a clinical setting. Dr. Nayak works at the Johns Hopkins Center for Psychedelic & Consciousness Research, he completed his MD at Brown University, his residency at Johns Hopkins, and is also currently a psychiatrist at Johns Hopkins Bayview Medical Center. We discussed the possible treatments for addiction, depression, and other mental health disorders/illnesses. We also breifly touched on cannabis (weed) and THC. These questions were sort of all over the place; I just had many questions out of my fascination on this topic. But of course, I think all of them were very interesting. I loved this conversation and I hope to have another one with Dr. Nayak in the future! I hope you enjoy:) More information on Dr. Sandeep Nayak: https://hopkinspsychedelic.org/nayak More Information on Psychedelic Research at Johns Hopkins: https://hopkinspsychedelic.org/ $15 Mental Health Poster on Patreon: https://www.patreon.com/sumoflife Instagram: https://www.instagram.com/sumoflifepodcast/ Website: http://sumoflife.org/ --- Support this podcast: https://anchor.fm/liam-scully/support